Search Results 811-820 of 17735 for corticosteroid

  1. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    disease in the moderate-to-severe range when attempting to wean off corticosteroids. 5. Has evidence of UC extending proximal to the rectum (i.e., not ...

  2. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis - Mayo Clinic

    -Demonstrated inadequate response to, loss of response to, or intolerance to at least one of the following: oral aminosalicylates, corticosteroids, ...

  3. A Study to Evaluate Pembrolizumab with Standard Therapy to Treat Newly-diagnosed Glioblastoma - Mayo Clinic

    ... corticosteroids or immunosuppressive drugs). ... NOTE: Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for ...

  4. Study to Evaluate the Effects of Vitamin B3 Derivative on Bone, Skeletal, Muscle and Metabolic Functions in Aging - Mayo Clinic

    History of oral or inhaled corticosteroid use > 3 months. Current use of anticoagulants in general. Anticonvulsant therapy (within previous year). Sodium ...

  5. Study of Magrolimab Combination Therapy to Treat Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    corticosteroids for at least 4 weeks) are allowed. - RBC transfusion dependence, defined as requiring more than 2 units of packed RBC transfusions during ...

  6. Impact of Age on Vaccine-Induced Activation of Human Inflammasome Complexes and Adaptive Immunity against Influenza Virus - Mayo Clinic

    If systemic corticosteroids have been administered short term for treatment of an acute illness, subjects will be excluded from the study until corticosteroid ...

  7. Study of M5049 in DM and PM Participants (NEPTUNIA) - Mayo Clinic

    * Stable doses of oral corticosteroids (CS) and/or maximum of 1 non-corticosteroid immunosuppressive/immunomodulatory medications (methotrexate, 6 ...

  8. Immunogenetics of COVID-19 Immune Response - Mayo Clinic

    Subjects on corticosteroids will be excluded if ≥ 20mg ... Subjects will be eligible if corticosteroid therapy has been discontinued for at least 30 days.

  9. Perfusion Assessment of Wound Closure Techniques in Primary Total Knee Arthroplasty - Mayo Clinic

    Systemic corticosteroid use; Active infection of any kind or chronic infection with HIV, Hepatitis C, or Syphilis. Participating Mayo Clinic locations. Study ...

  10. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

    stable without corticosteroids for a minimum of 3 weeks prior to the commencement of the study. Patients with neurologic symptoms must undergo a CT/MRI to ...